Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +0.51% | -2.94% | -0.50% |
May. 14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
May. 13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Exagen Inc.
Upcoming events on Exagen Inc.
Past events on Exagen Inc.
2024-06-10 09:00 am | Annual General Meeting |
2024-05-13 08:30 am | Q1 2024 Earnings Call |
2024-05-13 08:00 am | Q1 2024 Earnings Release |
2024-03-20 01:30 pm | KeyBanc Life Sciences & MedTech Forum |
2024-03-18 08:30 am | Q4 2023 Earnings Call |
2024-03-18 08:00 am | Q4 2023 Earnings Release |
2024-02-12 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
2023-11-16 09:30 am | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
2023-11-14 12:00 pm | American College of Rheumatology Conference - Abstract No: 2273 |
2023-11-13 04:30 pm | Q3 2023 Earnings Call |
2023-11-13 04:05 pm | Q3 2023 Earnings Release |
2023-11-12 12:00 pm | American College of Toxicology Meeting - Abstract No: 0576 |
2023-11-12 12:00 pm | American College of Toxicology Meeting - Abstract No: 0575 |
2023-11-12 12:00 pm | American College of Toxicology Meeting - Abstract No: 0557 |
2023-11-12 12:00 pm | American College of Toxicology Meeting - Abstract No: 0099 |
2023-09-26 08:45 am | Cantor Global Healthcare Conference |
2023-08-09 03:00 pm | Canaccord Genuity Growth Conference |
2023-08-07 08:30 am | Q2 2023 Earnings Call |
2023-08-07 08:00 am | Q2 2023 Earnings Release |
2023-06-09 11:00 am | Annual General Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 40,4 40,5 -0.36% | 42,0 40,0 4.98% | 48,3 47,3 2.04% | 45,6 41,8 9.13% | 52,5 50,3 4.42% | 55,8 |
EBITDA Million USD | Released Forecast Spread | -8,71 -9,50 8.34% | -14,6 -16,3 10.19% | -23,1 -24,1 4.07% | -39,0 -43,3 10.01% | -20,7 -20,0 -3.35% | -15,3 |
EBIT Million USD | Released Forecast Spread | -9,30 -10,5 11.61% | -15,2 -16,9 9.94% | -24,1 -25,4 5.32% | -40,5 -44,6 9.04% | -22,8 -24,7 7.72% | -19,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,0 -13,8 12.95% | -16,8 -18,2 7.92% | -26,7 -27,9 4.22% | -47,7 -46,6 -2.29% | -23,7 -26,1 9.19% | -21,0 |
Net income Million USD | Released Forecast Spread | -30,3 -13,8 -119.41% | -16,7 -18,1 7.96% | -26,9 -27,9 3.59% | -47,4 -46,6 -1.69% | -23,7 -25,9 8.62% | -21,4 |
EPS USD | Released Forecast Spread | -8,46 -1,96 -331.63% | -1,32 -1,43 7.85% | -1,68 -1,74 3.67% | -2,77 -2,70 -2.67% | -1,34 -1,47 9.09% | -1,18 |
Announcement Date | 25/03/20 | 16/03/21 | 22/03/22 | 20/03/23 | 18/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 10,4 10,00 3.96% | 8,96 12,0 -25.52% | 14,7 9,13 61.29% | 12,8 8,72 47.21% | 11,2 9,40 19.47% | 14,1 10,9 29.36% | 13,4 10,3 29.83% | 13,8 11,6 19.07% | 14,4 13,1 10.18% | 13,1 | 13,8 | 14,5 | 15,2 | 14,6 |
EBITDA Million USD | Released Forecast Spread | -9,40 -9,33 -0.76% | -12,4 -8,93 -38.87% | -7,38 -12,0 38.4% | -8,47 -12,5 32.42% | -7,15 -8,27 13.47% | -4,41 -7,70 42.7% | -4,47 -7,75 42.39% | -4,64 -6,80 31.78% | -2,55 -4,60 44.67% | -4,73 | -4,35 | -4,05 | -2,55 | -3,85 |
EBIT Million USD | Released Forecast Spread | -9,68 -9,74 0.63% | -12,7 -9,08 -39.96% | -7,82 -12,4 36.96% | -8,99 -13,0 30.88% | -7,71 -9,22 16.42% | -4,92 -8,42 41.63% | -5,07 -7,88 35.63% | -5,15 -7,08 27.25% | -3,00 -5,56 45.99% | -5,42 | -5,24 | -5,02 | -4,00 | -5,20 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,3 -10,3 0.51% | -13,3 -9,65 -37.92% | -8,10 -13,1 38.08% | -14,6 -13,6 -7.62% | -7,69 -9,78 21.35% | -5,01 -8,73 42.54% | -5,42 -8,15 33.56% | -5,54 -7,68 27.82% | -3,36 -6,30 46.67% | -5,98 | -5,83 | -5,85 | -4,45 | -5,70 |
Net income Million USD | Released Forecast Spread | -10,3 -10,3 0.51% | -13,3 -9,65 -37.92% | -8,10 -13,1 38.08% | -14,4 -13,6 -5.54% | -7,69 -9,78 21.35% | -5,01 -8,73 42.54% | -5,42 -8,15 33.56% | -5,57 -7,68 27.39% | -3,36 -6,30 46.67% | -5,98 | -5,83 | -5,85 | -4,45 | -5,70 |
EPS USD | Released Forecast Spread | -0,60 -0,61 1.32% | -0,78 -0,57 -37.81% | -0,47 -0,76 38.16% | -0,83 -0,76 -9.21% | -0,44 -0,56 21.15% | -0,28 -0,49 42.86% | -0,31 -0,46 33.19% | -0,31 -0,43 28.57% | -0,19 -0,36 47.51% | -0,34 | -0,33 | -0,33 | -0,27 | -0,29 |
Announcement Date | 11/05/22 | 04/08/22 | 14/11/22 | 20/03/23 | 15/05/23 | 07/08/23 | 13/11/23 | 18/03/24 | 13/05/24 | - | - | - | - | - |
Past sector events for Exagen Inc.
2024-05-29 02:40 pm | HEALTHCARE GLOBAL ENTERPRISES LIMITED: Q4 2024 Earnings Release |
2024-05-26 04:30 pm | RYMAN HEALTHCARE LIMITED: Q4 2024 Earnings Release |
2024-05-22 04:15 pm | AUNA S.A.: Q1 2024 Earnings Release |
2024-05-22 06:15 am | CORVEL CORPORATION: Q4 2024 Earnings Release |
2024-05-22 05:33 am | MAX HEALTHCARE INSTITUTE LIMITED: Q4 2024 Earnings Release |
2024-05-22 01:05 am | LIFE HEALTHCARE GROUP HOLDINGS LIMITED: Q2 2024 Earnings Release |
2024-05-16 09:32 pm | PT FAMON AWAL BROS SEDAYA TBK: Q1 2024 Earnings Release |
2024-05-16 08:15 am | KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED: Q4 2024 Earnings Release |
2024-05-15 | RAMKHAMHAENG HOSPITAL: Q1 2024 Earnings Release |
2024-05-14 | DIAGNOSTICOS DA AMÉRICA S.A.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XGN Stock
- Calendar Exagen Inc.